PALI Palisade Bio, Inc. Common Stock Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
15:52
Jul 15
Collin Kettell Founder & CEO, Palisades Goldcorp The David Lin Report
Leveraged junior mining bull market play
Palisades Goldcorp accumulated the largest public warrant book (1.7 billion warrants, 22 per share) during 2024-25 on favorable terms, providing massive upside leverage to a junior mining bull market with limited downside, and has already demonstrated 25x return potential on those warrants.
PALI 1ST
HIGH
14:06
Apr 13
A May MD Biotech investor
Buy PALI to exploit a relative value inefficiency, as competitors are gaining multiples of PALI's entire market cap based on inferior open-label clinical data.
PALI 1ST
MED

About PALI Analyst Coverage

Buzzberg tracks PALI (Palisade Bio, Inc. Common Stock) across 2 sources. 2 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (100%). 2 total trade ideas tracked. Past 7 days: 1 bullish. Latest voices: Collin Kettell, A May MD.